Certified by Founder Lodge
Tessera Therapeutics
United States - Cambridge, MA
START UP
1 Disclosed Funding Rounds $300,000,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Our mission is to cure disease by writing the code of life
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| April, 19 ,2022 | Series C | $300,000,000 |
Hanwha Impact Partners
March Capital
T. Rowe Price
Alaska Permanent Fund Corporation
ARTIS Ventures
Flagship Pioneering
Longevity Vision Fund
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Avallon AI (YC X25) | $4,600,000 | (Nov 7, 2025)
Kaizen Labs | $12,000,000 | (Nov 7, 2025)
SiteLabs | $2,000,000 | (Nov 7, 2025)
Fintary | $10,000,000 | (Nov 7, 2025)
Inception | $50,000,000 | (Nov 7, 2025)
